Scenarios that move RGNX
REGENXBIO Inc. - Common Stock
Scenarios that move RGNX: 4 analyses, 1 positive, 3 negative.
- · RARE's Fayuvi approval triggers second $203 million PRV sale — ▲ · impact +28 · confidence low · horizon quarters
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -50 · confidence low · horizon weeks
- · uniQure plunges after additional Huntington's disease study data — ▼ · impact -27 · confidence medium · horizon immediate
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▼ · impact -28 · confidence low · horizon weeks